Please use this identifier to cite or link to this item:
|Title:||Classification and tissue selectivity of calcium antagonists.|
|Authors:||Nayler, W G|
|Affiliation:||Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Australia.|
|Citation:||Zeitschrift Fu¨r Kardiologie; 79 Suppl 3(): 107-11|
|Abstract:||The Ca2+ antagonists are a chemically heterogeneous group of drugs which share the common property of attenuating Ca2+ influx through voltage-activated L-type Ca2(+)-selective channels. At least six criteria have been used as a basis of their classification: specificity of Ca2+ current inhibition, chemistry, tissue selectivity, salicylate sensitivity, calcium modulation and receptor specificity. Tissue selectivity provides a useful approach to classification and provides a useful basis on which to equate their relative usefulness as therapeutic agents. The basis of the tissue selectivity is probably complex and dependent not only upon the chemistry of the antagonist but also upon tissue-dependent differences in the composition of the alpha 1 subunit of the binding complex.|
|Internal ID Number:||1965934|
Calcium Channel Blockers.classification.pharmacology
Calcium Channels.drug effects
Muscle, Smooth, Vascular.drug effects
Nervous System.drug effects
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.